Northwest Biotherapeutics, Inc. (OTCMKTS:NWBO – Get Free Report) passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.55 and traded as low as $0.44. Northwest Biotherapeutics shares last traded at $0.44, with a volume of 1,151,307 shares.
Northwest Biotherapeutics Price Performance
The business’s 50 day simple moving average is $0.46 and its 200 day simple moving average is $0.55. The company has a market capitalization of $524.59 million, a PE ratio of -6.10 and a beta of -0.63.
Northwest Biotherapeutics (OTCMKTS:NWBO – Get Free Report) last posted its quarterly earnings data on Friday, May 10th. The biotechnology company reported ($0.02) EPS for the quarter. The company had revenue of $0.28 million for the quarter.
Northwest Biotherapeutics Company Profile
Northwest Biotherapeutics, Inc, a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer.
Further Reading
- Five stocks we like better than Northwest Biotherapeutics
- How to Calculate Stock Profit
- Qualcomm Stock: AI-Powered Growth Despite Volatility
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Salesforce Stock: Meeting Recap, AI Focus, and Forecast
- Insider Trades May Not Tell You What You Think
- Is CAVA Overextended? A Closer Look at This High-Flying Stock
Receive News & Ratings for Northwest Biotherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Northwest Biotherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
